Results 1 to 10 of about 271,938 (163)
Purinergic Signaling in Ovarian Carcinoma. [PDF]
Adv Pharm BullOvarian carcinoma (OC) is the most lethal gynecological cancer worldwide. Around 95% of patients exhibit recurrence five years after treatment; 80% experience recurrence within 18 months after first-line treatment, and progression-free survival rates have not changed over the past 40 years. New therapeutic approaches are imperative to face this complex
Martínez-Ramírez AS +4 more
europepmc +4 more sources
A rare case of pure-type embryonal carcinoma in a 75-year-old woman mimicking epithelial ovarian carcinoma [PDF]
Kosin Medical Journal, 2022 Embryonal carcinoma, a very rare ovarian germ cell tumor, involves pure and mixed phenotypes. Pure-type embryonal carcinoma has never been reported in postmenopausal women. The current case was, thus, misdiagnosed as an epithelial ovarian carcinoma based
Hyun Been Jo +7 more
doaj +1 more source
Expression Level of Cyclin-D1 between Endometriomas and Ovarian Carcinomes
Mutiara Medika, 2021 Endometrioma on the ovaries is a benign gynecological disorder that is often found in women of reproductive age. The approach was made to the malignant transformation through the study of cyclin-D1 expression.
Alfun Dhiya An +1 more
doaj +1 more source
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Journal of Ovarian Research, 2023 Background 2020 World Health Organization Classification of Female Genital Tumors removed ovarian seromucinous carcinoma as a distinct entity and recategorized it as ovarian endometrioid carcinoma with mucinous differentiation according to its ...
Yi Hu +6 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundOwing to its extremely low incidence and the paucity of relevant reports, there is currently no recognized first-line treatment strategy for ovarian large-cell neuroendocrine carcinoma, and there are no statistics related to prognosis derived ...
Li Pang, Zhiqiang Guo
doaj +1 more source
Carcinoma of Ovarian Teratoma [PDF]
The American Journal of the Medical Sciences, 1920 n ...
Clark, John G., Block, Frank B.
openaire +2 more sources
Epigenomics and Ovarian Carcinoma [PDF]
Biomarkers in Medicine, 2010 Ovarian cancer is the leading cause of death among gynecological cancers. It is now recognized that in addition to genetic alterations, epigenetic mechanisms, such as DNA methylation, histone modifications and nucleosome remodeling, play an important role in the development and progression of ovarian cancer by modulating chromatin structure, and gene ...
Leonel, Maldonado +1 more
openaire +2 more sources
Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
Diagnostics, 2021 Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our study, we compare a number of proteins from different effector pathways to assess their usefulness in the diagnosis of ovarian cancer.
Aneta Cymbaluk-Płoska +5 more
doaj +1 more source
Clinical Medicine Insights: Case Reports, 2023 Background: Clear cell ovarian carcinoma is rare and accounts for 1%-12% of ovarian epithelial carcinomas, depending on ethnicity. The prevalence of clear cell ovarian carcinoma in Asian, White, and Black women is 11.1%%, 4.8%, and 3.1%, respectively ...
Yoan Alexandria Angelina +1 more
doaj +1 more source
Diagnostics, 2021 The term “ovarian carcinoma” encompasses at least five different malignant neoplasms: high-grade serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, mucinous carcinoma, and clear cell carcinoma.
Giacomo Santandrea +7 more
doaj +1 more source